Imidafenacin
Template:Short description Template:Short description <templatestyles src="Infobox drug/styles.css"/> Script error: No such module "Infobox".Template:Template otherScript error: No such module "TemplatePar".{{Infobox drug/maintenance categoriesTemplate:Yesno | drug_name = | INN = | _drugtype =
| _has_physiological_data= | _has_gene_therapy=
| vaccine_type= | mab_type= | _number_of_combo_chemicals=Script error: No such module "ParameterCount". | _vaccine_data= | _mab_data= | _mab_vaccine_data= | _mab_other_data=202131CC1=NC=CN1CCC(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N1S/C20H21N3O/c1-16-22-13-15-23(16)14-12-20(19(21)24,17-8-4-2-5-9-17)18-10-6-3-7-11-18/h2-11,13,15H,12,14H2,1H3,(H2,21,24)SQKXYSGRELMAAU-UHFFFAOYSA-NTemplate:StdinchiciteTemplate:Stdinchicite | _combo_data= | _physiological_data= | _clinical_data= By mouthG04 | _legal_data=Rx-only
| _other_data=4-(2-Methyl-1H-imidazol-1-yl)-2,2-diphenylbutanamide
| _image_0_or_2 = Imidafenacin.svg | _image_LR =
| _datapage = Imidafenacin (data page) | _vaccine_target=_type_not_vaccine | _legal_all=Rx-only | _ATC_prefix_supplemental=G04 | _has_EMA_link = | CAS_number=170105-16-5 | PubChem=6433090 | ChemSpiderID=4938278 | ChEBI= | ChEMBL=53366 | DrugBank= | KEGG= | _hasInChI_or_Key=yes | UNII=XJR8Y07LJO | _hasJmol02 = |_hasMultipleCASnumbers = |_hasMultiplePubChemCIDs = |_hasMultipleChEBIs =
| _countSecondIDs=Script error: No such module "ParameterCount". | _countIndexlabels=Script error: No such module "ParameterCount". | _trackListSortletter= |QID = |QID2 = |Verifiedfields=changed |Watchedfields= |verifiedrevid=444484151}}
Imidafenacin (INN) is a urinary antispasmodic of the anticholinergic class.[1] It is used for the treatment of urinary incontinence and related bladder issues, especially in patients with benign prostatic hyperplasia or who have had prostate surgery. Unlike most related drugs, it is orally active but still shows a rapid onset of action, which makes it more convenient to administer.[2][3][4]
References
<templatestyles src="Reflist/styles.css" />
- ↑ Script error: No such module "Citation/CS1".
- ↑ Mostafaei H, Salehi-Pourmehr H, Jilch S, Carlin GL, Mori K, Quhal F, Pradere B, Grossmann NC, Laukhtina E, Schuettfort VM, Aydh A, Sari Motlagh R, König F, Roehrborn CG, Katayama S, Rajwa P, Hajebrahimi S, Shariat SF. Choosing the Most Efficacious and Safe Oral Treatment for Idiopathic Overactive Bladder: A Systematic Review and Network Meta-analysis. Eur Urol Focus. 2022 Jul;8(4):1072-1089. Script error: No such module "CS1 identifiers". Template:Pmid
- ↑ Su YT, Chen HL, Teoh JY, Chan VW, Wu WJ, Lee HY. Comparison of add-on medications for persistent storage symptoms after α-blocker treatment in BPH patients - a network meta-analysis. BMC Urol. 2023 Oct 3;23(1):154. Script error: No such module "CS1 identifiers". Template:Pmid
- ↑ Lee JH, Goh HJ, Lee K, Choi DW, Lee KM, Kim S. Efficacy and safety evaluation of imidafenacin administered twice daily for continency recovery following radical prostatectomy in prostate cancer patients: Prospective open-label case-controlled randomized trial. Investig Clin Urol. 2024 Sep;65(5):466-472. Script error: No such module "CS1 identifiers". Template:Pmid
Script error: No such module "Check for unknown parameters".
Template:Urologicals Template:Muscarinic acetylcholine receptor modulators